Acessibilidade / Reportar erro

Quality of life of patients with graft-versus-host disease (GvHD) post-hematopoietic stem cell transplantation* * Extracted from the dissertation “Qualidade de vida nos 100 dias do transplante de células-tronco hematopoéticas”, Universidade Federal do Paraná, 2015.

Calidad de Vida de Pacientes Post Trasplante de Células Madre Hematopoyéticas con Enfermedad del Injerto Contra Huésped

Abstract

OBJECTIVE

Assessing the quality of life of adult patients with hematological cancer in the 100 days after transplantation of hematopoietic stem cells and verifying whether the variable graft-versus-host disease (GvHD) is predictive of worse results.

METHOD

An observational correlational and quantitative study with 36 adult participants diagnosed with hematologic cancer who underwent hematopoietic stem cell transplantation from September 2013 to June 2015.

RESULT

The mean age was 37 years, 52.78% were female, and 61.11% were diagnosed with leukemia. Quality of life scores showed a significant impact between pre-transplantation and pre-hospital discharge, and also within the 100 days post-transplantation. The statistical analysis between the scores for the groups with and without GvHD showed a significant difference between the presence of the complication and worse results.

CONCLUSION

Quality of life is altered as a result of hematopoietic stem cells transplantation, especially in patients who have graft-versus-host disease.

Descriptors
Quality of Life; Hematopoietic Stem Cell Transplantation; Graft vs Host Disease; Oncology Nursing

Universidade de São Paulo, Escola de Enfermagem Av. Dr. Enéas de Carvalho Aguiar, 419 , 05403-000 São Paulo - SP/ Brasil, Tel./Fax: (55 11) 3061-7553, - São Paulo - SP - Brazil
E-mail: reeusp@usp.br